We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Systemic therapy and radiotherapy related complications and subsequent hospitalisation rates: a systematic review

    Background

    Hospitalisation  resulting from complications of systemic therapy and radiotherapy places a substantial burden on the patient, society, and...

    Rashidul Alam Mahumud, Md. Shahjalal, ... Olivia Wawryk in BMC Cancer
    Article Open access 10 July 2024
  2. Impact of primary resistance to front-line targeted therapy in metastatic renal cell carcinoma on subsequent immune-checkpoint-inhibition

    Introduction

    Synergistic effects have been discussed for tyrosine kinase (TKI) and immune checkpoint inhibitors (ICI). Primary resistance to TKI might...

    J. H. Börner, S. Neuberger, ... R. Mager in Discover Oncology
    Article Open access 23 September 2023
  3. Pan-cancer assessment of antineoplastic therapy-induced interstitial lung disease in patients receiving subsequent therapy immediately following immune checkpoint blockade therapy

    Background

    Drug-induced interstitial lung disease (DIILD) is a serious adverse event potentially induced by any antineoplastic agent. Whether cancer...

    Yoshihiro Kitahara, Yusuke Inoue, ... Takafumi Suda in Respiratory Research
    Article Open access 10 January 2024
  4. Continuation of Buprenorphine During Hospitalization and Subsequent Retention in Therapy: an Observational Study in Veterans Administration Hospitals

    Background

    Inpatient hospitalization has the potential to disrupt buprenorphine therapy.

    Objective

    Among patients receiving outpatient buprenorphine...

    Hilary J. Mosher, Katherine Hadlandsmyth, ... Brian C. Lund in Journal of General Internal Medicine
    Article 26 September 2023
  5. Progression patterns, resistant mechanisms and subsequent therapy for ALK-positive NSCLC in the era of second-generation ALK-TKIs

    Background

    In the era of second-generation ALK tyrosine kinase inhibitors (ALK-TKIs), there was a paucity of data regarding the progression patterns,...

    Lige Wu, Zihua Zou, ... Puyuan **ng in Journal of Translational Medicine
    Article Open access 20 June 2024
  6. Arterial Stiffness May Predict Subsequent Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Patients

    Cancer therapy-related cardiac dysfunction (CTRCD) is still a serious problem. Existing risk scores are insufficient for risk classification,...

    Mürsel Şahin, Seher Nazlı Kazaz, ... Merih Kutlu in Cardiovascular Toxicology
    Article Open access 08 March 2024
  7. Outcomes of surgery and subsequent therapy for central nervous system oligoprogression in EGFR-mutated NSCLC patients

    Background

    Oligoprogression is an emerging issue in patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC)....

    Pang-Shuo Perng, Heng-Juei Hsu, ... Po-Hsuan Lee in World Journal of Surgical Oncology
    Article Open access 25 November 2023
  8. Interaction-focused music therapy with cancer-affected children and their significant others: a randomized controlled feasibility study with subsequent intervention (INMUT)

    Background

    Paediatric oncology/haematology patients and their families are confronted with a life-threatening situation for which music therapy can be...

    Constance Boyde, Bettina Berger, ... Christina Hunger-Schoppe in Pilot and Feasibility Studies
    Article Open access 28 May 2024
  9. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

    Background

    There is no standard treatment recommended at category 1 level in international guidelines for subsequent therapy after cyclin-dependent...

    Cengiz Karacin, Berna Oksuzoglu, ... İlhan Hacıbekiroğlu in BMC Cancer
    Article Open access 10 February 2023
  10. Testosterone replacement therapy is associated with increased odds of Achilles tendon injury and subsequent surgery: a matched retrospective analysis

    Background

    Prescription of testosterone replacement therapy (TRT) has increased in the United States in recent years, and though anabolic steroids...

    J. Alex Albright, Mary Lou, ... Michel Arcand in Journal of Foot and Ankle Research
    Article Open access 11 November 2023
  11. Subsequent primary neoplasms after childhood cancer therapy – design and description of the German nested case–control study STATT-SCAR

    Background

    Subsequent primary neoplasms (SPN) are among the most severe late effects and the second most frequent cause of death in childhood cancer...

    Peter Scholz-Kreisel, Cornelia Becker, ... Claudia Spix in Cancer Causes & Control
    Article Open access 02 August 2023
  12. Untreated hypogonadism and testosterone replacement therapy in hypogonadal men are associated with a decreased risk of subsequent prostate cancer: a population-based study

    We sought to understand the relationship between hypogonadism and testosterone replacement therapy (TRT) in hypogonadal men on the risk of develo**...

    Kian Asanad, Joshua J. Horns, ... James M. Hotaling in International Journal of Impotence Research
    Article 05 January 2024
  13. Subsequent treatment for locally advanced non-small-cell lung cancer that progressed after definitive chemoradiotherapy and consolidation therapy with durvalumab: a multicenter retrospective analysis (TOPGAN 2021-02)

    Purpose

    For patients with locally advanced non-small-cell lung cancer (LA-NSCLC) that progressed after definitive chemoradiotherapy (CRT) and...

    Tsukasa Hasegawa, Ryo Ariyasu, ... Makoto Nishino in Cancer Chemotherapy and Pharmacology
    Article 27 May 2023
  14. Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profile

    Background

    The long-term immunologic effects of antiretroviral therapy (ART) in children with perinatally-acquired HIV (PHIV) have not been fully...

    Athena N. Nguyen, Alec L. Plotkin, ... Cissy Kityo in Pediatric Research
    Article 13 June 2023
  15. Reliability of Magseed® marking before neoadjuvant systemic therapy with subsequent contrast-enhanced mammography in patients with non-palpable breast cancer lesions after treatment: the MAGMA study

    Purpose

    To assess the reliability of excising residual breast cancer lesions after neoadjuvant systemic therapy (NAST) using a previously localized...

    Eva Iglesias Bravo, Antonio Mariscal Martínez, ... Anabel García Barrado in Breast Cancer Research and Treatment
    Article Open access 20 June 2024
  16. The cycle effect quantified: reduced tumour uptake in subsequent cycles of [177Lu]Lu-HA-DOTATATE during peptide receptor radionuclide therapy

    Background

    Clear evidence regarding the effect of reduced tumour accumulation in later peptide receptor radionuclide therapy (PRRT) cycles is lacking....

    H. Siebinga, J. J. M. A. Hendrikx, ... B. J. de Wit-van der Veen in European Journal of Nuclear Medicine and Molecular Imaging
    Article 16 October 2023
  17. Subsequent management and outcomes after first-line PARP inhibitors progression in ovarian cancer patients

    Objectives

    This retrospective study aims to evaluating the subsequent management and outcomes after first-line PARPi progression in Chinese ovarian...

    Hua Yuan, Ning Li, ... Hongwen Yao in Journal of Ovarian Research
    Article Open access 01 April 2024
  18. Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy

    Almost all patients with multiple myeloma (MM) will eventually develop disease that has relapsed with or become refractory to available treatments...

    Noopur Raje, María-Victoria Mateos, ... Donna Reece in Blood Cancer Journal
    Article Open access 22 March 2023
  19. Physical Therapy

    The role of the physical therapist and physical therapist assistant in providing home care services on an interprofessional team is vital. Physical...
    Gilaine Nettles, Revenda Greene, ... Bridgette Stasher-Booker in Home Care for Older Adults Using Interprofessional Teams
    Chapter 2024
  20. Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)

    Background

    Although osimertinib is a promising therapeutic agent for advanced epidermal growth factor receptor ( EGFR ) mutation-positive lung cancer,...

    Naoya Nishioka, Hisao Imai, ... Hiroaki Okamoto in Targeted Oncology
    Article Open access 13 April 2024
Did you find what you were looking for? Share feedback.